{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:14:44Z","timestamp":1785420884666,"version":"3.56.0"},"reference-count":25,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV006726"],"award-info":[{"award-number":["INV006726"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"award":["INV006726"],"award-info":[{"award-number":["INV006726"]}],"id":[{"id":"https:\/\/ror.org\/0456r8d26","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Clinical Feasibility grant","award":["INV-051718"],"award-info":[{"award-number":["INV-051718"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: The continued evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) created ongoing challenges for molecular diagnostics and variant surveillance. Assays capable of maintaining diagnostic sensitivity across emerging variants while providing variant-related information remain essential for clinical and public health applications. This study evaluated the performance of the GXT96 X3 extraction kit in combination with the FluoroType\u00ae SARS-CoV-2 varID Q version 1.0 assay (Hain LifeScience SA (Pty) Ltd., South Africa) for the detection, semi-quantitative assessment, and variant characterization of SARS-CoV-2 under laboratory conditions. Methods: A total of 220 samples were evaluated, including residual nasopharyngeal clinical specimens (n = 183), reference materials, and cultured SARS-CoV-2 virus dilutions. Residual specimens collected during multiple COVID-19 waves in South Africa (wild-type, Beta, Delta, and Omicron) were compared against standard-of-care (SOC) molecular assays used for routine diagnosis. RNA extraction was performed using the automated GXT96 X3 platform, followed by amplification on the FluoroCycler\u00ae XT using the FluoroType\u00ae SARS-CoV-2 varID Q assay targeting RdRp and N genes, with additional spike gene mutation detection for variant detection. Diagnostic accuracy, agreement (Cohen\u2019s kappa), precision, linearity, and limit of detection (LoD) were assessed. Results: The assay demonstrated a sensitivity of 98.4% (95% CI: 94.2\u201399.8) and specificity of 100% (95% CI: 95.9\u2013100.0) compared with SOC assays, with an overall agreement of \u03ba = 0.981. Precision analysis showed acceptable reproducibility with a standard deviation of \u22641.49 and a coefficient of variation of \u22643.83%. Regression analysis demonstrated linearity across the dilution series (R2 = 0.9882 for RdRp and 0.994 for N genes). The LoD was \u2264100 copies\/mL for the RdRp gene and 250 copies\/mL for the N gene. Variant-associated spike mutations corresponded broadly with epidemiological wave patterns observed in South Africa. Conclusions: Under the evaluated laboratory conditions, the GXT96 X3 extraction platform combined with the FluoroType\u00ae SARS-CoV-2 varID Q assay demonstrated high diagnostic accuracy and reproducibility for SARS-CoV-2 detection across a range of viral loads with additional spike gene mutation detection as an adjunct feature.<\/jats:p>","DOI":"10.3390\/diagnostics16131951","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:11:49Z","timestamp":1782234709000},"page":"1951","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Performance Evaluation of the GXT96 X3 Extraction System with the FluoroType\u00ae SARS-CoV-2 varID Q Assay for SARS-CoV-2 Detection and Mutation Screening"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5007-5295","authenticated-orcid":false,"given":"Riffat","family":"Munir","sequence":"first","affiliation":[{"name":"Wits Diagnostic Innovation Hub, Faculty of Health Sciences, University of Witwatersrand, Johannesburg 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1225-8098","authenticated-orcid":false,"given":"Oluwakemi","family":"Laguda-Akingba","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Faculty of Health Sciences, Walter Sisulu University, Mthatha 5117, South Africa"},{"name":"National Health Laboratory Service, Gqeberha 6001, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6573-9525","authenticated-orcid":false,"given":"Lesley Erica","family":"Scott","sequence":"additional","affiliation":[{"name":"Wits Diagnostic Innovation Hub, Faculty of Health Sciences, University of Witwatersrand, Johannesburg 2193, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1684-908X","authenticated-orcid":false,"given":"Wendy Susan","family":"Stevens","sequence":"additional","affiliation":[{"name":"Wits Diagnostic Innovation Hub, Faculty of Health Sciences, University of Witwatersrand, Johannesburg 2193, South Africa"},{"name":"National Priority Program, National Health Laboratory Services, Johannesburg 2131, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., and Duan, G. (2020). Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses, 12.","DOI":"10.3390\/v12040372"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","article-title":"COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses","volume":"24","author":"Shereen","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"10196","DOI":"10.1021\/acs.analchem.0c02060","article-title":"Molecular diagnosis of COVID-19: Challenges and research needs","volume":"92","author":"Feng","year":"2020","journal-title":"Anal. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3349\/ymj.2021.62.11.961","article-title":"SARS-CoV-2 variants of concern","volume":"62","author":"Choi","year":"2021","journal-title":"Yonsei Med. J."},{"key":"ref_6","first-page":"20499361211024372","article-title":"The emerging SARS-CoV-2 variants of concern","volume":"8","author":"Sanyaolu","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lin, L., Liu, Y., Tang, X., and He, D. (2021). The disease severity and clinical outcomes of the SARS-CoV-2 variants of concern. Front. Public Health, 9.","DOI":"10.3389\/fpubh.2021.775224"},{"key":"ref_8","first-page":"41295","article-title":"Emergence of COVID-19 variants: An update","volume":"15","author":"Gupta","year":"2023","journal-title":"Cureus"},{"key":"ref_9","first-page":"480","article-title":"The emergence of SARS-CoV-2 Omicron subvariants: Current situation and future trends","volume":"30","author":"Farahat","year":"2022","journal-title":"Le. Infez. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1002\/mco2.172","article-title":"Sub-lineages of the SARS-CoV-2 Omicron variants: Characteristics and prevention","volume":"3","author":"Xu","year":"2022","journal-title":"MedComm"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41563-020-00906-z","article-title":"Diagnostics for SARS-CoV-2 infections","volume":"20","author":"Kevadiya","year":"2021","journal-title":"Nat. Mater."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2020.08.002","article-title":"Molecular diagnostic technologies for COVID-19: Limitations and challenges","volume":"26","author":"Afzal","year":"2020","journal-title":"J. Adv. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00253-020-11061-5","article-title":"Detection technologies and recent developments in the diagnosis of COVID-19 infection","volume":"105","author":"Rai","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.pathol.2021.11.006","article-title":"Clinical associations of SARS-CoV-2 viral load using the first WHO international standard for SARS-CoV-2 RNA","volume":"54","author":"Boan","year":"2022","journal-title":"Pathology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1002\/iid3.580","article-title":"The relationship between COVID-19 viral load and disease severity: A systematic review","volume":"10","author":"Dadras","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1553-2712.1996.tb03538.x","article-title":"Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity","volume":"3","author":"Buderer","year":"1996","journal-title":"Acad. Emerg. Med."},{"key":"ref_18","unstructured":"(2025, June 18). Specification Criteria for COVID-19 Molecular Meril COVID-19 One-Step RT-PCR Kits MD018: SAHPRA. Available online: https:\/\/www.sahpra.org.za\/medical-devices\/medical-devices-and-in-vitro-diagnostics-test-kits\/."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Poljak, M., Korva, M., Knap Ga\u0161per, N., Fujs Komlo\u0161, K., Sagadin, M., Ur\u0161i\u010d, T., Av\u0161i\u010d \u017dupanc, T., and Petrovec, M. (2020). Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic. J. Clin. Microbiol., 58.","DOI":"10.1128\/JCM.00599-20"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"104869","DOI":"10.1016\/j.jcv.2021.104869","article-title":"Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay","volume":"140","author":"Perchetti","year":"2021","journal-title":"J. Clin. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1940","DOI":"10.1002\/rmv.1940","article-title":"Basic overview of method validation in the clinical virology laboratory","volume":"27","author":"Newman","year":"2017","journal-title":"Rev. Med. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/bs.acc.2019.01.006","article-title":"A practical guide to validation and verification of analytical methods in the clinical laboratory","volume":"90","author":"Pum","year":"2019","journal-title":"Adv. Clin. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Subramoney, K., Mtileni, N., Giandhari, J., Naidoo, Y., Ramphal, Y., Pillay, S., Ramphal, U., Maharaj, A., Tshiabuila, D., and Tegally, H. (2023). Molecular epidemiology of SARS-CoV-2 during five COVID-19 waves and the significance of low-frequency lineages. Viruses, 15.","DOI":"10.3390\/v15051194"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"104561","DOI":"10.1016\/j.ebiom.2023.104561","article-title":"In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters","volume":"91","author":"Furusawa","year":"2023","journal-title":"EBioMedicine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41592-023-01769-3","article-title":"Outbreak.info genomic reports: Scalable and dynamic surveillance of SARS-CoV-2 variants and mutations","volume":"20","author":"Gangavarapu","year":"2023","journal-title":"Nat. Methods"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/1951\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:35:38Z","timestamp":1782236138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/1951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":25,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["diagnostics16131951"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16131951","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}